Skip to main content

3 Reasons to Sell CLAR and 1 Stock to Buy Instead

CLAR Cover Image

Shareholders of Clarus would probably like to forget the past six months even happened. The stock dropped 22.8% and now trades at $3.25. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.

Is there a buying opportunity in Clarus, or does it present a risk to your portfolio? See what our analysts have to say in our full research report, it’s free.

Why Do We Think Clarus Will Underperform?

Despite the more favorable entry price, we don't have much confidence in Clarus. Here are three reasons why we avoid CLAR and a stock we'd rather own.

1. Long-Term Revenue Growth Disappoints

A company’s long-term sales performance can indicate its overall quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Unfortunately, Clarus’s 2.9% annualized revenue growth over the last five years was weak. This was below our standards. Clarus Quarterly Revenue

2. EPS Trending Down

Analyzing the long-term change in earnings per share (EPS) shows whether a company's incremental sales were profitable – for example, revenue could be inflated through excessive spending on advertising and promotions.

Sadly for Clarus, its EPS declined by 16.5% annually over the last five years while its revenue grew by 2.9%. This tells us the company became less profitable on a per-share basis as it expanded.

Clarus Trailing 12-Month EPS (Non-GAAP)

3. New Investments Fail to Bear Fruit as ROIC Declines

A company’s ROIC, or return on invested capital, shows how much operating profit it makes compared to the money it has raised (debt and equity).

We like to invest in businesses with high returns, but the trend in a company’s ROIC is what often surprises the market and moves the stock price. Over the last few years, Clarus’s ROIC has unfortunately decreased significantly. Paired with its already low returns, these declines suggest its profitable growth opportunities are few and far between.

Clarus Trailing 12-Month Return On Invested Capital

Final Judgment

Clarus doesn’t pass our quality test. Following the recent decline, the stock trades at 8.2× forward EV-to-EBITDA (or $3.25 per share). This valuation tells us it’s a bit of a market darling with a lot of good news priced in - we think there are better opportunities elsewhere. We’d recommend looking at the most dominant software business in the world.

High-Quality Stocks for All Market Conditions

Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.

While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.